Cargando...

Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis

BACKGROUND: Rituximab has been used in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) since 2003. Our objective was to describe outcomes and adverse events following rituximab since that time in an inception cohort. METHODS: Patients with AAV (diagnosed 1991–2012) who receive...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Nephrol Dial Transplant
Autores principales: McGregor, JulieAnne G., Hogan, Susan L., Kotzen, Elizabeth S., Poulton, Caroline J., Hu, Yichun, Negrete-Lopez, Roberto, Kidd, Jason M., Katsanos, Suzanne L., Bunch, Donna O., Nachman, Patrick H., Falk, Ronald J.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2015
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4447867/
https://ncbi.nlm.nih.gov/pubmed/25805743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfv076
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!